Alzheimer's disease (AD) is a common, debilitating neurodegenerative disease affecting about 10 percent of people over the age of 65 and one third of people aged 85 and above. Besides environmental ...

INmune Bio's ATM offering raises $19M ahead of Phase II results, but disappointing data and dilution signal risks. Read here ...

The pursuit of a cure for Alzheimer's disease is becoming an increasingly competitive and contentious quest with recent years witnessing several important controversies.

New research reveals that Alzheimer's disease may impair nerve function not by reducing myelin, but by altering the proteins ...

Tulane University researchers created a first-of-its-kind subcellular map of an area of the brain commonly affected by ...

FlyBase, the world's only fruit fly database, is in the crosshairs of Trump's attack on Harvard. Here's why it could matter ...

A collaborative team of researchers has succeeded in revealing the high-resolution structures of amyloid β (Aβ40) fibrils ...

A new study has revealed that newborn babies and Alzheimer’s patients both have elevated levels of the same protein, p-tau217 ...

Newborn babies and patients with Alzheimer's disease share an unexpected biological trait: elevated levels of a well-known ...

Newborn babies and patients with Alzheimer's disease share an unexpected biological trait: elevated levels of a well-known ...

Some bacteria form protective communities called biofilms, which rely on amyloid assemblies (similar in structure to the plaques ... may actually interfere with the molecular events that lead to ...

Every three seconds, someone in the world develops dementia. Alzheimer’s disease is the most common form of dementia, accounting for between 60% and 70% of all cases. Although scientists have made ...